港股隨A股升幅擴至近200點重越二萬八關 手機/電訊/內需股領漲
內地新冠肺炎新增確診病例2,048宗，累計確診個案增至70,548宗，死亡人數累增至1,770宗，逾萬人康復。人行今天開展2,000億人民幣MLF操作，利率下調10點子至3.15%。此外，人行今天重啟逆回購操作金額1,000億人民幣。滬指及深成繼上周累彈41點及近2.9%後，今早高開0.3%及0.5%，升幅擴至1.2%及1.7%，分別報2,951及11,101。板塊方面，除生物疫苗、流感及醫癈處理逆軟外，全部造好，逾三分二升幅超過1%-3%；國防軍工、通信、海南板塊、大飛機及農業種植更依次漲逾4%-5%；但重磅內銀及白酒僅升不足0.3%；內房升0.7%。
港股繼上周續累升411點或1.5%後，今早低開48點或近0.2%報27,766獲承接，掉頭高見28,018，創三周新高，現造28,012，倒升197點或0.7%，成交額370億元。
藍籌股普遍造好，尤其是吉利汽車(00175.HK)重越100天及50天線(14.51-14.72元)，最高見15.08元，現造14.98元，回升3.5%；蒙牛(02319.HK)、萬洲(00192.HK)及旺旺(00151.HK)逾1.5%-2%，後者最強股價重越10天線，最高見6.48元，現造6.45元，續升2%。
兩大手機股瑞聲(02018.HK)及舜宇(02382.HK)重越10天線，分別報59.3元及133.3元，回升3.2%及2.3%。中移動(00941.HK)及聯通(00762.HK)升2%及1.5%，分別報66.4元及6.81元。此外，銀娛(00027.HK)及中石化(00386.HK)反覆續升1.7%，分別報58.2元及4.28元。
金融股以友邦(01299.HK)及國壽(02628.HK)表現最好，股價升約1.5%，分別報81.75元及19.58元，前者重越20天及50天線(81.57元)，後者重越10天線(19.42元)。不過，明天放榜的匯控(00005.HK)逆吐0.4%報59.4元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app！
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
